Revolutionizing Data Capture through Integrated Patient Experience Platforms
Clinical trials are fundamentally changing the way patient experience data is captured. In a time when regulators are putting much greater emphasis on patient-focused drug…
Clinical trials are fundamentally changing the way patient experience data is captured. In a time when regulators are putting much greater emphasis on patient-focused drug…
In recent years, research peptides have gained increasing attention within scientific and academic communities. These compounds, composed of short chains of amino acids, are widely…
Key Points AI chaos is a success-driven challenge: Powerful, specialized AI tools are proliferating faster than labs can integrate them coherently. Fragmentation creates hidden costs:…
Earlier this year, the U.K. government announced £82.6 million ($102.2 million) in research funding for artificial intelligence (AI) companies engaged in developing solutions that accelerate…
Over the past several years, Medical Affairs has evolved from a largely supportive, reactive function into a primary strategic pillar. In 2026, proving the value…
Open-source adoption is modernising statistical workflows amidst a clinical trial environment mired in vast datasets, complex endpoints and increasing regulatory scrutiny. Sponsors are under pressure…
For more than a decade life sciences organisations have spoken confidently about becoming data-driven; more recently about becoming AI-powered. Yet compared with other highly-regulated sectors,…
Whether for pathology or pharmaceutical purposes, laboratory space in the UK is in shortage – an issue not just for individual businesses but for the…
The UK’s National Health Service (NHS) is increasingly struggling to meet its diagnostic targets. As of August 2025, over 1.6 million people were on waiting…
As 2026 approaches, the pharmaceutical industry faces a new test in vaccine logistics. The lessons of recent years have shown just how fragile global cold…